$1.38
0.010.73%
In chiusura: Nov 18, 4:00 PM EST
$1.35
-0.03-2.17%
Post-mercato: 4:00 PM EST
Century Therapeutics (IPSC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.11 | $-0.11 | 0.00 % |
| Q2 | Aug 12, 2026 | $-0.17 | $-0.12 | -41.7 % |
| Q1 | May 13, 2026 | $-0.11 | $-0.17 | 35.3 % |
| Q4 | Mar 12, 2026 | $-0.25 | $-0.29 | 13.8 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | Mar 12, 2026 | $0 | $-62.50K | 100.0 % |
| Q3 | Nov 13, 2025 | $0 | $25.00K | -100.0 % |
| Q1 | May 15, 2025 | $109.16M | $45.52M | 139.8 % |
| Q4 | Mar 19, 2025 | $4.17M | $975.00K | 328.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.12 | $-0.17 | $-0.29 |
| Actual | $-0.11 | $-0.17 | $-0.11 | $-0.25 |
| Surprise | 0.00% | -41.7% | +35.3% | +13.8% |
| Revenue | ||||
| Estimate | — | — | — | $-62500 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | +100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.12 | $-0.12 | $-0.13 | $-0.13 |
| Revenue | ||||
| Consensus | — | — | — | — |
